The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Eosinophilic and Noneosinophilic Asthma
Open accessAbstract
Background Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe asthma cohorts. Research Question What is the prevalence of eosinophilic and noneosinophilic phenotypes in the population with severe asthma, and can these phenotypes be differentiated by clinical and biomarker variables? Study Design and Methods This was an historical registry study. Adult patients with severe asthma and available blood eosinophil count (BEC) from 11 countries enrolled in the International Severe Asthma Registry (January 1, 2015-September 30, 2019) were categorized according to likelihood of eosinophilic phenotype using a predefined gradient eosinophilic algorithm based on highest BEC, long-term oral corticosteroid use, elevated fractional exhaled nitric oxide, nasal polyps, and adult-onset asthma. Demographic and clinical characteristics were defined at baseline (ie, 1 year before or closest to date of BEC). Results One thousand seven hundred sixteen patients with prospective data were included; 83.8% were identified as most likely (grade 3), 8.3% were identified as likely (grade 2), and 6.3% identified as least likely (grade 1) to have an eosinophilic phenotype, and 1.6% of patients showed a noneosinophilic phenotype (grade 0). Eosinophilic phenotype patients (ie, grades 2 or 3) showed later asthma onset (29.1 years vs 6.7 years; P < .001) and worse lung function (postbronchodilator % predicted FEV 1 , 76.1% vs 89.3%; P = .027) than those with a noneosinophilic phenotype. Patients with noneosinophilic phenotypes were more likely to be women (81.5% vs 62.9%; P = .047), to have eczema (20.8% vs 8.5%; P = .003), and to use anti-IgE (32.1% vs 13.4%; P = .004) and leukotriene receptor antagonists (50.0% vs 28.0%; P = .011) add-on therapy. Interpretation According to this multicomponent, consensus-driven, and evidence-based eosinophil gradient algorithm (using variables readily accessible in real life), the severe asthma eosinophilic phenotype was more prevalent than previously identified and was phenotypically distinct. This pragmatic gradient algorithm uses variables readily accessible in primary and specialist care, addressing inherent issues of phenotype heterogeneity and phenotype instability. Identification of treatable traits across phenotypes should improve therapeutic precision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Self-citationFitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
Self-citationA double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Kuruvilla, M. E., Lee, F. E.-H., & Lee, G. B. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8712-1 · Cited by 1,228
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073 · cited 2×
“treatment.(1) Finally, we pooled diverse data from large severe asthma registries to provide a real-life phenotype snapshot at the global and country levels, quantifying and characterizing both the severe eosinophilic phenotype and also the often-ignored noneosinophilic severe asthma phenotype, which historically has…”
BackgroundMethodSelf-citationWagener, A. H., de Nijs, S. B., Lutter, R., Sousa, A. R., Weersink, E. J. M., Bel, E. H., & Sterk, P. J. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205634 · Cited by 429
Chronic Rhinosinusitis with Nasal Polyps and Asthma
Laidlaw, T. M., Mullol, J., Woessner, K. M., Amin, N., & Mannent, L. P. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.09.063 · Cited by 419
Eosinophilic and Noneosinophilic Asthma
Carr, T. F., Zeki, A. A., & Kraft, M. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2232pp · Cited by 351
Characterization of Severe Asthma Worldwide
Wang, E., Wechsler, M. E., Tran, T. N., Heaney, L. G., Jones, R. C., Menzies-Gow, A. N., Busby, J., Jackson, D. J., Pfeffer, P. E., Rhee, C. K., et al. (2020) · Chest · doi:10.1016/j.chest.2019.10.053 · Cited by 351
Self-citationFitzGerald, J. M., Bleecker, E. R., Menzies-Gow, A., Zangrilli, J. G., Hirsch, I., Metcalfe, P., Newbold, P., & Goldman, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30344-2 · Cited by 318
Self-citationUnsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data
Wu, W., Bleecker, E., Moore, W., Busse, W. W., Castro, M., Chung, K. F., Calhoun, W. J., Erzurum, S., Gaston, B., Israel, E., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.042 · Cited by 310
Korevaar, D. A., Westerhof, G. A., Wang, J., Cohen, J. F., Spijker, R., Sterk, P. J., Bel, E. H., & Bossuyt, P. M. M. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00050-8 · Cited by 282
Mechanisms and therapeutic strategies for non‐T2 asthma
Sze, E., Bhalla, A., & Nair, P. (2020) · Allergy · doi:10.1111/all.13985 · Cited by 259
TREATMENT OF CHRONIC ASTHMA WITH PREDNISOLONE SIGNIFICANCE OF EOSINOPHILS IN THE SPUTUM
Morrow Brown, H. (1958) · The Lancet · doi:10.1016/s0140-6736(58)91385-0 · Cited by 233
Acute and chronic systemic corticosteroid–related complications in patients with severe asthma
Lefebvre, P., Duh, M. S., Lafeuille, M.-H., Gozalo, L., Desai, U., Robitaille, M.-N., Albers, F., Yancey, S., Ortega, H., Forshag, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.046 · Cited by 214
Severe eosinophilic asthma: a roadmap to consensus
Buhl, R., Humbert, M., Bjermer, L., Chanez, P., Heaney, L. G., Pavord, I., Quirce, S., Virchow, J. C., & Holgate, S. (2017) · European Respiratory Journal · doi:10.1183/13993003.00634-2017 · Cited by 188
Self-citationKerkhof, M., Tran, T. N., Soriano, J. B., Golam, S., Gibson, D., Hillyer, E. V., & Price, D. B. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210531 · Cited by 160
Self-citation“T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin
Pavlidis, S. P., Takahashi, K., Kwong, F. N. K., Xie, J., Hoda, U., Sun, K., Elyasigomari, V., Agapow, P., Loza, M. J., Baribaud, F., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00938-2018 · Cited by 155
Heaney, L. G., Busby, J., Hanratty, C. E., Djukanović, R., Woodcock, A. A., Walker, S. M., Hardman, T. C., Arron, J. R., Choy, D. F., Bradding, P., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30397-0 · Cited by 152
Self-citationValidated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study
Loza, M. J., Djukanović, R., Chung, K. F., Horowitz, D. M., Ma, K., Branigan, P. J., Barnathan, E. S., Susulic, V. S., Silkoff, P. E., Sterk, P. J., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0482-9 · Cited by 143
Bakakos, A., Loukides, S., & Bakakos, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091375 · Cited by 129
Frøssing, L., Silberbrandt, A. W., von Bülow, A., Backer, V., & Porsbjerg, C. M. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.09.051 · Cited by 116
Self-citationAdult‐onset eosinophilic airway diseases
Asano, K., Ueki, S., Tamari, M., Imoto, Y., Fujieda, S., & Taniguchi, M. (2020) · Allergy · doi:10.1111/all.14620 · Cited by 111
Bernstein, J. A., Virchow, J. C., Jr., Murphy, K. R., Maspero, J. F., Jacobs, J., Adir, Y., Humbert, M. J. C., Castro, M., Marsteller, D. A., McElhattan, J., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30372-8 · Cited by 87
Self-citationPrice, D. B., Bosnic-Anticevich, S. Z., Pavord, I. D., Roche, N., Halpin, D. M. G., Bjermer, L. H., Usmani, O. S., Brusselle, G., Ming, S. W. Y., & Rastogi, S. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0282-7 · Cited by 78
Self-citationBurgel, P., Paillasseur, J.-L., & Roche, N. (2014) · BioMed Research International · doi:10.1155/2014/420134 · Cited by 76
Sputum Induction in Severe Asthma by a Standardized Protocol
Brinke, A. T., de LANGE, C., Zwinderman, A. H., Rabe, K. F., Sterk, P. J., & Bel, E. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2009035 · Cited by 74
Schäper, C., Noga, O., Koch, B., Ewert, R., Felix, S., Gläser, S., Kunkel, G., & Gustavus, B. (2011) · PubMed · Cited by 73
International severe asthma registry (ISAR): protocol for a global registry
FitzGerald, J. M., Tran, T. N., Alacqua, M., Altraja, A., Backer, V., Bjermer, L. H., Björnsdóttir, U. S., BOURDIN, A. A., Brusselle, G., Bulathsinhala, L., et al. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01065-0 · Cited by 66
Self-citationDevelopment of the International Severe Asthma Registry (ISAR): A Modified Delphi Study
Bulathsinhala, L., Eleangovan, N., Heaney, L. G., Menzies-Gow, A. N., Gibson, P. G., Peters, M. J., Hew, M. J., van Boven, J. F. M., Lehtimäki, L. A., Ganse, E. H. V., et al. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.08.016 · Cited by 62
Self-citationInternational Severe Asthma Registry
Canonica, G. W., Alacqua, M., Altraja, A., Backer, V., Bel, E. H., Bjermer, L. H., Björnsdóttir, U. S., BOURDIN, A. A., Brusselle, G., Christoff, G., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.10.051 · Cited by 60
Self-citationBusse, W. W., Humbert, M. J. C., Haselkorn, T., Ortiz, B. D., Trzaskoma, B. L., Stephenson, P. A., Conde, L. G., Kianifard, F., & Holgate, S. T. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.11.016 · Cited by 55
Azim, A., Newell, C., Barber, C., Harvey, M., Knight, D., Freeman, A. T., Fong, W. C. G., Dennison, P., Haitchi, H. M., Djukanović, R., et al. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13841 · Cited by 53
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes
Azim, A., Freeman, A. T., Lavenu, A., Mistry, H. M., Haitchi, H. M., Newell, C., Cheng, Y., Thirlwall, Y., Harvey, M., Barber, C., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.05.053 · Cited by 45
Validation of ATS clinical practice guideline cut-points for FeNO in asthma
Jeppegaard, M., Veidal, S., Sverrild, A., Backer, V., & Porsbjerg, C. M. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.09.014 · Cited by 26
Self-citationPrevention of Chronic Obstructive Pulmonary Disease
Papi, A. A., Morandi, L., & Fabbri, L. M. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.05.004 · Cited by 17
Management of Severe Asthma Beyond the Guidelines
Reihman, A. E., Holguín, F., & Sharma, S. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00940-6 · Cited by 12
The Lancet Asthma Commission: Towards the Abolition of Asthma?
Bush, A., & Pavord, I. D. (2018) · European Medical Journal · doi:10.33590/emj/10312015 · Cited by 8
Cited by
Biologics and airway remodeling in severe asthma
Varricchi, G., Ferri, S., Pepys, J., Poto, R., Spadaro, G., Nappi, E., Paoletti, G., Virchow, J. C., Heffler, E., & Canonica, W. G. (2022) · Allergy · doi:10.1111/all.15473 · Cited by 254
Self-citation
Metadata
- Authors
- Heaney, L. G., Perez de Llano, L., Al-Ahmad, M., Backer, V., Busby, J., Canonica, G. W., Christoff, G. C., Cosio, B. G., FitzGerald, J. M., Heffler, E., Iwanaga, T., Jackson, D. J., Menzies-Gow, A. N., Papadopoulos, N. G., Papaioannou, A. I., Pfeffer, P. E., Popov, T. A., Porsbjerg, C. M., Rhee, C. K., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M. E., Alacqua, M., Altraja, A., Bjermer, L., Björnsdóttir, U. S., Bourdin, A., Brusselle, G. G., Buhl, R., Costello, R. W., Hew, M., Koh, M. S., Lehmann, S., Lehtimäki, L., Peters, M., Taillé, C., Taube, C., Tran, T. N., Zangrilli, J., Bulathsinhala, L., Carter, V. A., Chaudhry, I., Eleangovan, N., Hosseini, N., Kerkhof, M., Murray, R. B., Price, C. A., & Price, D. B.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 160
- Issue
- 3
- Pages
- 814-830
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W3152894658
- Cited by
- 282
- References
- 41
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.